Public Company News

Erayak Power Solution Group Inc. Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy

WENZHOU, China, Oct. 17, 2025 /PRNewswire/ -- Erayak Power Solution Group Inc. ("Erayak" or the "Company") (Nasdaq: RAYA), a leading manufacturer and exporter of advanced power solution products, today announced the establishment of its U.S. subsidiary, Nexora Group Inc., marking a strategic mile...

2025-10-17 18:16 2131

SEMIFIVE Submits Securities Registration for KOSDAQ Listing

* Secures Only 'One-Stop AI ASIC Solution' in Korea and Big-Die Design Capability * 2025 Q3 Cumulative Revenue Expected to Surpass KRW 90 Billion; Large AI Chip Mass Production Begins, Growth to Accelerate from Q4 * Wins Successive AI Chip Design Projects for Global Customers, Expanding int...

2025-10-17 17:25 1454

NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC. TO HOLD ANNUAL GENERAL MEETING ON NOVEMBER 21, 2025

BEIJING, Oct. 17, 2025 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU and SEHK: 9901), a provider of private educational services inChina, today announced that it will hold an annual general meeting (the "AGM") of shareholders (the "Not...

2025-10-17 17:00 1393

FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States

* YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications – adolescent hidradenitis suppurativa (HS) and pediatric uveitis (UV), in the U.S.[1],[2] * Pediatric UV is a rare eye inflammation in children, representing 5–10% of all uveitis...

2025-10-17 13:32 1253

Compal Showcases Comprehensive Data Center Solutions at 2025 OCP Global Summit; Unveils SGX30-2 High-Performance AI Server Built with NVIDIA HGX™ B300

SAN JOSE, Calif., Oct. 16, 2025 /PRNewswire/ -- Global data centers are facing new challenges driven by AI – greater compute demand, larger working sets, and more stringent energy efficiency requirements. At this year's OCP Global Summit, Compal Electronics (Compal; Ticker: 2324.TW) presented a c...

2025-10-17 00:00 1333

Clarity signs copper-67 Supply Agreement with Nusano

SYDNEY, Oct. 16, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a Supp...

2025-10-16 21:04 1333

Hyundai Mobis wins awards at three global advertising festivals with 'Move Improved' campaign

* Selected as a finalist in the 'Corporate Online Media – Social Media Videos' category at the 16th Cannes Corporate Media & TV Awards... the only Korean company in the list * Also won top prizes at North American global advertising festivals '2025 Muse Creative Award' and '2025 NYX Award' ...

2025-10-16 20:00 1616

Canadian Solar Schedules Third Quarter 2025 Earnings Conference Call for November 13

KITCHENER, ON, Oct. 16, 2025 /PRNewswire/ -- Canadian Solar Inc . ("the Company", "Canadian Solar") (NASDAQ: CSIQ) today announced that it will hold a conference call onThursday, November 13, 2025, at 8:00 a.m. U.S. Eastern Time (9:00 p.m., November 13, 2025, in Hon...

2025-10-16 19:00 1233

HD Hyundai Electric Accelerates Expansion into the North American Low- and Medium-Voltage Circuit Breaker Market with UL Certification

* Secures UL and cUL certifications for four types of low- and medium-voltage circuit breakers, reinforcing competitiveness inNorth America * Global low- and medium-voltage circuit breaker market projected to reach USD 29.2 billion by 2034, growing at a CAGR of 8.8% * "The company plans to e...

2025-10-16 12:28 875

HARMONi-6 Phase III Study of Ivonescimab Accepted by The Lancet and Selected for ESMO 2025 LBA Presentation

HONG KONG, Oct. 16, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) today announced that the groundbreaking results from the registrational Phase III AK112-306/HARMONi-6 study of ivonescimab have been accepted for publication in The Lancet. The study evaluated ivonescimab, a first-in-class PD-1/VEGF b...

2025-10-16 12:15 1330

Jacobio Pharma Announces Strategic Partnership with Oceanpine Capital to Focus on Core Oncology Pipeline

BEIJING and SHANGHAI and BOSTON, Oct. 15, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) today announced that its subsidiary, Beijing Jacobio Pharmaceuticals Co., Ltd. ("Beijing Jacobio"), has entered into a Capital Increase and Equity Transfer Agreement with Oceanpine Capital and an industry part...

2025-10-15 23:05 1943

Fibocom Unveils Cutting-Edge 5G FWA Portfolio Featuring MediaTek T930 at NetworkX 2025

PARIS, Oct. 15, 2025 /PRNewswire/ -- Fibocom, a leading global provider of wireless communication modules and AI solutions, introduced its new series of 5G FWA solutions powered by the MediaTek T930 platform. The lineup includes the FG390-NA module, featuring advanced RF integration and full comp...

2025-10-15 23:04 1153

CJ BIO Showcases Science-Backed Nutrition Solutions at SSG 2025

DOWNERS GROVE, Ill., Oct. 15, 2025 /PRNewswire/ -- CJ BIO, a global leader in functional health and nutrition solutions, will join SupplySide Global 2025 under the theme "Where Function Meets Clinical Proof." The company will present science-backed Nutrition Solutions for muscle health, beauty, a...

2025-10-15 22:00 1255

Extend full-chain guarantee mechanism globally: EPWK builds a bridge of trust for cross-border creative transactions

XIAME, China, Oct. 15, 2025 /PRNewswire/ -- Recently, EPWK International (intl.epwk.com) has officially launched its operations, attracting thousands of users from across the globe to register daily. Successful internationalization will help EPWK completely transform from a local Chinese company ...

2025-10-15 20:00 1135

SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia

* Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses * Phase 1/2 study to enroll ~500 healthy adults, with topline results expected by 2028 * We aim to build a universal Sarbecovirus vaccine platform to proactively address future pandemics SEONGNAM, South Kor...

2025-10-15 20:00 1164

Cango Inc. to Terminate ADR Program and List Class A Ordinary Shares Directly on NYSE

HONG KONG, Oct. 15, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company") today announced that its board of directors has approved the termination of its American depository receipt ("ADR") program*. The ADR program and the related Deposit Agreement are expected to terminate aft...

2025-10-15 18:00 1475

Yum China to Report Third Quarter 2025 Financial Results

SHANGHAI, Oct. 15, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9987, "Yum China" or the "Company") today announced that it will report its unaudited financial results for the third quarter endedSeptember 30, 2025 before the U.S. market opens on Tuesday, November 4, 2025 (a...

2025-10-15 17:00 1108

Recon Technology, Ltd Reports Financial Year Results for Fiscal Year 2025

BEIJING, Oct. 14, 2025 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company"), aChina-based independent solutions integrator in the oilfield service and environmental protection, electric power and coal chemical industries, today announced its financial results for fiscal...

2025-10-15 04:30 1929

Alcor Micro to Showcase Latest Arm-based CPU Platform "Mobius100 (CSS V3)" at OCP Global Summit 2025

SAN JOSE, Calif., Oct. 14, 2025 /PRNewswire/ -- Alcor Micro (8054.TWO), a subsidiary of Egis Technology Inc. (6462.TWO), will participate in the Open Compute Project (OCP) Global Summit 2025 held inSan Jose, California, to showcase its latest Arm-based CPU platform — Mobius100 (CSS V3). The 8-cor...

2025-10-15 01:00 4676

Mabwell Announces Latest Clinical Results of Novel B7-H3-Targeting ADC 7MW3711 to Be Presented at 2025 ESMO Congress

SHANGHAI, Oct. 14, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that clinical research results of its novel B7-H3-targeting ADC (R&D code: 7MW3711) for multiple advanced solid tumors, will be presented as a poster at the E...

2025-10-15 00:00 1469
1 ... 24252627282930 ... 778

Week's Top Stories